Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
暂无分享,去创建一个
M. Kramer | A. Shitrit | M. Raz | D. Shlomi | D. Shitrit | A. Lavy | G. Baum | R. Priess | B. Daniele
[1] R. Wallace,,et al. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] F. Caballero-Granado,et al. Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] F. Alcaide,et al. Epidemiology of Mycobacterium kansasii , 1999, Annals of Internal Medicine.
[4] Horsburgh Cr,et al. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989 .
[5] I. D. Johnston,et al. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. , 1996, Thorax.
[6] R. Shafer,et al. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. R. Deyoung,et al. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii , 1984, Antimicrobial Agents and Chemotherapy.
[8] I. D. Johnston,et al. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. , 1996, Thorax.
[9] D. Snider,et al. Isolation of nontuberculous mycobacteria in the United States, 1980. , 1982, The Journal of infectious diseases.
[10] J. Watson,et al. Opportunist mycobacteria in England and Wales: 1982 to 1994. , 1996, Communicable disease report. CDR review.
[11] A. Telenti,et al. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies , 1997, Journal of clinical microbiology.
[12] B. Ross,et al. Identification of Mycobacterium kansasii by DNA hybridization , 1991, Journal of clinical microbiology.
[13] R. Chaisson,et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. , 1999, American journal of respiratory and critical care medicine.
[14] F. Alcaide,et al. EPIDEMIOLOGY OF MYCOBACTERIUM KANSASII. AUTHORS' REPLY , 1999 .
[15] R. Wallace,,et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. , 1990, The American review of respiratory disease.
[16] S. Hoffner,et al. Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[17] D. Griffith. Management of disease due to Mycobacterium kansasii. , 2002, Clinics in chest medicine.
[18] R. Mera,et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] E. H. Shuford,et al. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. , 1979, Chest.
[20] R. Hayes,et al. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. , 1999, American journal of respiratory and critical care medicine.
[21] D. Snider,et al. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. , 1987, The American review of respiratory disease.
[22] P. Carpentier. Nouvelles m??thodes d????valuation clinique de la microcirculation cutan??e , 1999 .
[23] E. Wolinsky. Editorial: When is an Infection Disease? , 1981 .
[24] R. Leithiser,et al. The changing epidemiology of tuberculosis and other mycobacterial infections in the United States: implications for the radiologist. , 1991, AJR. American journal of roentgenology.
[25] R. Harris,et al. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. , 1990, Reviews of infectious diseases.
[26] H. Libshitz,et al. Mycobacterium kansasii infections in patients with cancer. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] J. Gerberding,et al. Incidence and Clinical Implications of Isolation of Mycobacterium kansasii: Results of a 5-Year, Population-Based Study , 1998, Annals of Internal Medicine.
[28] K. Kooguchi,et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. , 2001, American journal of respiratory and critical care medicine.
[29] J. Marks. "Opportunist" mycobacteria in England and Wales. , 1969, Tubercle.
[30] D. Podzamczer,et al. Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain , 2004, Epidemiology and Infection.